Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

9 results about "Oral Lozenge" patented technology

A juhong powder for respiratory health, its preparation method and application

The present invention provides a tangerine peel powder for respiratory health, its preparation method and application. The tangerine peel powder further enhances the protective effect on the respiratory tract by soaking and fermenting papaya juice and adding essential oil components. The present invention combines hot air drying and freeze drying, which not only avoids the destruction of active ingredients by high temperature, but also improves the re-dissolution property through the porous structure of freeze drying, facilitating the rapid release of active ingredients. The tangerine peel in the present invention mainly functions to resolve phlegm and relieve cough, and the fermented papaya juice assists in promoting digestion and regulating the stomach, reducing the generation of phlegm-dampness. At the same time, the anti-inflammatory effect is enhanced through flavonoid components. Peppermint and litsea cubeba essential oils assist in anti-inflammation and soothe the throat, possibly forming a multi-level respiratory protection mechanism. The final product of the present invention is in powder form and can be added to different final products, such as sprays, oral lozenges, creams, etc., to expand its scope of application.
Owner:FOSHAN GOLDEN HEALTH TECH CO LTD

Throat lozenge packaging can (Maikele Blue Fatty)

ActiveCN309231095SOral LozengePackaging Tank
1. The name of the product of this design: Throat Lozenge Packaging Can (MacLe Blue Fatty). 2. Purpose of the product of this design: for packaging of oral lozenges. 3. The design key point of this appearance design product lies in the combination of shape and pattern. 4. The picture or photo that best illustrates the design points: Stereoscopic diagram 1.
Owner:JIANGSU RONGYU VALLEY INTERNATIONAL TRADE CO LTD

Oral lozenge with anti-inflammatory and bacteriostatic effects

The invention provides an oral lozenge with anti-inflammatory and bacteriostatic effects. The oral lozenge comprises the following components in parts by weight: 50-80 parts of a dandelion extract, 20-40 parts of catechin, 20-60 parts of a hydrogen source disintegrating agent, 1-10 parts of a surfactant, 1-5 parts of a flavoring agent and 0.5-3 parts of a preservative. The prepared oral lozenge has a high bacteriostasis rate on staphylococcus aureus, candida albicans, porphyromonas gingivalis and streptococcus mutans, is low in swelling value and good in anti-inflammatory effect, and can effectively inhibit bacteria and treat inflammation when being applied to the oral cavity.
Owner:HYDROGEN CITY HYDROGEN CITY (SHANDONG) BIOENERGY CO LTD

Exocarpium powder for respiratory tract health as well as preparation method and application of exocarpium powder

The invention provides exocarpium powder for respiratory tract health as well as a preparation method and application of the exocarpium powder. The exocarpium powder is soaked in the fermented papaya juice and added with the essential oil component, so that the protection effect on the respiratory tract is further enhanced. Through the combination of hot air drying and freeze-drying, active ingredients are prevented from being damaged by high temperature, the redissolvability is improved through a freeze-drying porous structure, and quick release of the active ingredients is facilitated. The exocarpium citri grandis is mainly used for preventing phlegm from forming and stopping coughing, the fermented papaya juice is used for assisting in resolving dampness and harmonizing the stomach, phlegm dampness is reduced, and meanwhile the anti-inflammatory effect is enhanced through flavonoid components. The mint and the pungent litse fruit essential oil can assist in resisting inflammation and relieving the throat, and a multi-layer respiratory tract protection mechanism can be possibly formed. The final product is powdery and can be added into different final products, such as sprays, substitutional tea, oral lozenges, paste and the like; and the application range is expanded.
Owner:FOSHAN GOLDEN HEALTH TECH CO LTD

A Visualized Anti-Caries Probiotic Tablet and Its Preparation Method

PendingCN122075555AReduce Streptococcus mutans levelsincrease diversityDigestive systemUnknown materialsBiotechnologyMouth care
This invention discloses a visual anti-caries probiotic lozenge and its preparation method, belonging to the field of pediatric oral care technology. The invention uses *Lactobacillus rhamnosus* SD11 as the core functional strain, employing spray drying technology for single-layer microcapsule encapsulation, combined with a pH-responsive natural pigment color development mechanism, and compounded with xylitol, calcium carbonate, and vitamin D3 to produce an oral lozenge. This product inhibits cariogenic bacteria by regulating the oral microecology, achieving caries prevention, and visually indicates oral health status through color changes. Simultaneously, the strain can reach the intestines to exert systemic regulatory effects. This invention utilizes spray drying microencapsulation and dry granulation processes, resulting in high production efficiency, stable quality, and advantages such as high safety, good compliance, clear efficacy, and suitability for industrial production. It is suitable for long-term daily use by children aged 2-12 years.
Owner:BEIJING MINGYANG DENTAL CLINIC CO LTD

Composition of probiotics and traditional chinese medicines for treating insomnia and use thereof

PCT designated stageWO2026145472A1BiotechnologyStaphylococcus lactis
A composition for treating insomnia, comprising a probiotic complex and traditional Chinese medicine components. The probiotic complex comprises Lactobacillus plantarum, Bifidobacterium lactis, Lactobacillus crispatus, Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum, Lactobacillus reuteri, Lactobacillus casei, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus fermentum, Lactobacillus gasseri, Lactococcus lactis, Bifidobacterium longum, Lactobacillus salivarius, Bifidobacterium breve, Streptococcus thermophilus, Lactobacillus paracasei and Lactobacillus helveticus. The traditional Chinese medicine components are semen ziziphi spinosae, bulbus lilii, poria, semen nelumbinis and mori fructus. The composition may further comprise prebiotics selected from L-arabinose, β-glucan, inulin, erythritol, lactitol, vitamin C and γ-aminobutyric acid. The composition can be used for preparing pharmaceutical or food formulations, such as solid beverages, chewable tablets or oral lozenges. Clinical observation shows that the composition has the effect of relieving insomnia.

Oral buccal tablet and preparation method thereof

The invention discloses an oral lozenge in the field of oral pharmaceutical preparations, which is prepared from the following raw materials in parts by weight: 10-30 parts of snow pear, 5-15 parts of honeysuckle, 5-15 parts of orange peel, 5-15 parts of kudzuvine root, 5-15 parts of loquat, 5-15 parts of momordica grosvenori, 3-10 parts of liquorice, 3-10 parts of boat-fruited sterculia seed, 3-10 parts of almond, 3-10 parts of mint, 1-5 parts of galangal, 1-5 parts of lily, mannitol and peach gum. According to the oral lozenge disclosed by the invention, the quick-release pellets and the sustained-release pellets are scientifically proportioned, and mannitol in the quick-release pellets is used as a carrier, so that the oral lozenge can quickly release components with cooling and throat-moistening effects within 5-10 minutes after being taken, and acute uncomfortable symptoms such as throat dry itching and pain can be quickly relieved; and the sustained-release pellets are wrapped by peach gum and can continuously release components with antibacterial, anti-inflammatory, cough-relieving and sputum-reducing effects within 2-5 hours, so that the organic combination of quick action and long-acting treatment is realized.
Owner:ZUNYI MEDICAL UNIVERSITY